Huaying Dong

1.4k total citations
11 papers, 215 citations indexed

About

Huaying Dong is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huaying Dong has authored 11 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 8 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huaying Dong's work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (4 papers) and RNA Research and Splicing (3 papers). Huaying Dong is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (4 papers) and RNA Research and Splicing (3 papers). Huaying Dong collaborates with scholars based in China, United States and Hong Kong. Huaying Dong's co-authors include Wei Wang, Jing Han, Fan Zhang, Jianguo Hu, Lei Liu, Nian Wu, Yuanwen Chen, Xionghui He, Mulin Ye and Kejian Zou and has published in prestigious journals such as Archives of Biochemistry and Biophysics, Molecular Therapy and Journal of Cellular and Molecular Medicine.

In The Last Decade

Huaying Dong

10 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huaying Dong China	6	176	163	29	20	14	11	215
Christine How Canada	6	216 1.2×	202 1.2×	17 0.6×	18 0.9×	12 0.9×	8	263
Zheng Zhi China	6	283 1.6×	245 1.5×	25 0.9×	16 0.8×	22 1.6×	8	330
Ulvi Ahmadov Denmark	6	182 1.0×	159 1.0×	23 0.8×	10 0.5×	10 0.7×	7	210
Xiao-Peng Tian China	4	199 1.1×	169 1.0×	21 0.7×	11 0.6×	26 1.9×	5	244
Andrés Lanzós Switzerland	3	239 1.4×	234 1.4×	14 0.5×	25 1.3×	11 0.8×	3	266
Panhong Liu China	5	145 0.8×	129 0.8×	17 0.6×	9 0.5×	44 3.1×	7	177
Xinya Tong China	7	313 1.8×	183 1.1×	26 0.9×	10 0.5×	20 1.4×	12	332
Alcida Karz United States	2	238 1.4×	187 1.1×	32 1.1×	9 0.5×	16 1.1×	6	263
Assia Konsoulova Bulgaria	5	116 0.7×	120 0.7×	36 1.2×	11 0.6×	13 0.9×	21	173
Shanxun Yu China	5	340 1.9×	339 2.1×	16 0.6×	23 1.1×	19 1.4×	6	367

Countries citing papers authored by Huaying Dong

Since Specialization

Citations

This map shows the geographic impact of Huaying Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaying Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaying Dong more than expected).

Fields of papers citing papers by Huaying Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaying Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaying Dong. The network helps show where Huaying Dong may publish in the future.

Co-authorship network of co-authors of Huaying Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Huaying Dong. A scholar is included among the top collaborators of Huaying Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaying Dong. Huaying Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Dong, Huaying, et al.. (2024). LncRNA ZNF649-AS1 promotes trastuzumab resistance and TAM-dependent PD-L1 expression in breast cancer by regulating EXOC7 alternative splicing. Archives of Biochemistry and Biophysics. 761. 110128–110128. 2 indexed citations

Chen, Xiang, Changcheng Yang, Kejian Zou, et al.. (2024). Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer. PeerJ. 12. e17419–e17419.

Dong, Huaying, et al.. (2023). Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis. Breast Cancer. 30(6). 1028–1040. 11 indexed citations

Hu, Junjie, et al.. (2023). 16S full-length gene sequencing analysis of intestinal flora in breast cancer patients in Hainan Province. Molecular and Cellular Probes. 71. 101927–101927. 5 indexed citations

Chen, Xiang, Changcheng Yang, Wei Wang, et al.. (2023). Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis. Frontiers in Genetics. 14. 1025163–1025163. 3 indexed citations

Zhong, Guansheng, Dajiang Song, Weiyang Lou, et al.. (2023). Pathological complete response rate and clinical outcome after neoadjuvant therapy of HER2-low breast cancer: A National Cancer Database Analysis. European Journal of Surgical Oncology. 49(11). 106970–106970. 4 indexed citations

Deng, Yujiao, Hongtao Li, Yi Zheng, et al.. (2021). Impact of Preoperative vs Postoperative Radiotherapy on Overall Survival of Locally Advanced Breast Cancer Patients. Frontiers in Oncology. 11. 779185–779185. 7 indexed citations

Chen, Yuanwen, et al.. (2020). microRNA‐128‐3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down‐regulating NEK2. Journal of Cellular and Molecular Medicine. 24(13). 7353–7369. 36 indexed citations

Han, Mingli, Xueke Qian, Hui Cao, et al.. (2020). lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy. Molecular Therapy. 28(11). 2488–2502. 44 indexed citations

10.

Chen, Yuanwen, Nian Wu, Lei Liu, Huaying Dong, & Chun‐Ying Wu. (2019). Correlation between microRNA-21, microRNA-206 and estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 in breast cancer. Clinical Biochemistry. 71. 52–57. 10 indexed citations

11.

Dong, Huaying, Wei Wang, Shaowei Mo, et al.. (2018). Long non‐coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation. Journal of Cellular and Molecular Medicine. 22(10). 4935–4947. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact